Semax/Selank
This IPS-listed option is reviewed privately during consultation. Details are reviewed privately during consultation.
Cognitive peptide education
A cognitive-support blend discussed for clinician-guided focus, mental clarity, stress-resilience, and neuro-support conversations when lifestyle, sleep, medications, and health history have been reviewed.
Overview
Semax is a synthetic nootropic peptide derived from an ACTH fragment. It is commonly discussed for cognitive-support goals because of its relationship to neurotrophic signaling, neurotransmitter balance, and cerebral circulation pathways.
IPS currently lists Semax in a Semax/Selank blend rather than as a standalone item. That means the consultation should cover both cognitive-performance goals and stress-resilience context before a protocol is considered.
IPS access
This entry comes from the IPS access available list. Final route, timing, duration, and candidacy depend on consultation, availability, and clinician judgment.
This IPS-listed option is reviewed privately during consultation. Details are reviewed privately during consultation.
Semax as a nootropic peptide for cognitive-support and neuroprotective conversations.
Medication use, anxiety, sleep, neurological history, and cognitive goals should be reviewed before use.
Mechanism
Semax is commonly framed around neurotrophic-factor signaling, neurotransmitter modulation, cerebral blood-flow support, and oxidative-stress resilience. IPS keeps the discussion grounded in measurable goals and appropriate medical screening.
Semax is often discussed around BDNF and NGF pathways that support brain-health conversations.
Patients may ask about attention, mental stamina, learning, and recall without stimulant-style effects.
Because IPS lists Semax with Selank, stress resilience, anxiety tendency, and sleep quality matter in screening.
Sleep, nutrition, training load, caffeine use, medications, and workload often shape the plan as much as the peptide.
Process
Review focus, memory, mood, sleep, stress, workload, stimulant use, and health history.
Screen neurological history, medications, psychiatric history, blood pressure concerns, and contraindications.
If appropriate, your clinician reviews route, timing, frequency, expectations, storage, and monitoring.
Follow-up tracks tolerance, sleep, mood, focus, clarity, and whether the plan should change.
Safety & candidacy
IPS reviews medical history, neurological conditions, mood or anxiety concerns, sleep quality, stimulant use, current medications, pregnancy-related factors where applicable, and whether symptoms require primary-care or specialist evaluation first.
Questions
Yes. This option is in the IPS available list when applicable. Protocol details are reviewed privately during consultation.
intranasal administration as common, while noting some protocols may use other routes. IPS reviews route during consultation.
Semax is discussed differently than stimulant medications. Any focus or clarity goals should be reviewed with sleep, caffeine, medications, mood, and health history.
No. New, worsening, or concerning cognitive symptoms should be evaluated by the appropriate clinician.
Contact
Complete the form and IPS will follow up about consultation scheduling and next steps.